Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsUbiquitous LEA29Y Expression Blocks T Cell Co-Stimulation but Permits Sexual Reproduction in Genetically Modified PigsProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy.Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.CD28 Costimulation: From Mechanism to Therapy.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.Belatacept for renal rescue in lung transplant patients.Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy.NO AUGMENTATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY THROUGH BELATACEPT TREATMENT IN LIVER TRANSPLANT RECIPIENTS.What's Hot, What's New From the 2016 American Transplant Congress.The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.
P2860
Q26774993-9236F177-8FB2-4F9D-8947-4A7B9AD08AFAQ27346701-A2911B87-E257-43BD-A657-3E55878F8996Q30245002-98FD77B2-4D85-459B-9910-1D21736F8A4EQ30815289-2B67A766-2CB3-4E73-A397-DAE4F9C2CDDFQ33806623-73AEB9BB-8235-46BB-9D01-FA9445B66BEEQ38307029-E360A423-B4ED-4124-865F-16A825F4C285Q38682284-C4569717-2C51-4E7C-A455-71A6F60002FAQ38737314-D878F435-D7CA-4749-A23A-B98406D8DB86Q38757060-83850DFF-A1C8-4963-837F-D900431F55E9Q38786418-0525CB6E-1B37-46E5-BEDC-1CD44EB8DF79Q38837466-78D2A049-2C36-4DFF-8D4F-575190A060DFQ38918124-A272FB46-3EA6-4C67-A51A-2FFC72243DE9Q39350215-4BF4B2A1-DF7F-4C0D-83D7-2CF55EB9BFADQ40201063-EA01DA19-4BE6-43FF-BF17-341D22C8C7D4Q41627118-8193390F-9166-4AB2-BDAD-C0999F0702AFQ47260341-4503B9D4-415A-4DC4-A156-A7CACF81DB93Q51316622-B86075D4-425F-4C83-B756-60CF9EF5654FQ55692477-79472C25-D9F6-44D7-82E8-03BB3EC060BA
P2860
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Belatacept-based immunosuppres ...... m a phase II randomized study.
@ast
Belatacept-based immunosuppres ...... m a phase II randomized study.
@en
Belatacept-based immunosuppres ...... m a phase II randomized study.
@nl
type
label
Belatacept-based immunosuppres ...... m a phase II randomized study.
@ast
Belatacept-based immunosuppres ...... m a phase II randomized study.
@en
Belatacept-based immunosuppres ...... m a phase II randomized study.
@nl
prefLabel
Belatacept-based immunosuppres ...... m a phase II randomized study.
@ast
Belatacept-based immunosuppres ...... m a phase II randomized study.
@en
Belatacept-based immunosuppres ...... m a phase II randomized study.
@nl
P2093
P2860
P50
P356
P1476
Belatacept-based immunosuppres ...... m a phase II randomized study.
@en
P2093
G B Klintmalm
J-C Garcia-Valdecasas
L Rostaing
M B Harler
S Meadows-Shropshire
P2860
P304
P356
10.1111/AJT.12810
P407
P577
2014-08-01T00:00:00Z